VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis

Atherosclerosis

Volumn 200, Issue 1, 2008, Pages 51-57

  Fujii, Takaaki ^a,c   Yonemitsu, Yoshikazu ^b   Onimaru, Mitsuho ^a   Inoue, Makoto ^d   Hasegawa, Mamoru ^d   Kuwano, Hiroyuki ^c   Sueishi, Katsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d DNAVEC Corporation   (Japan)

Author keywords

FGF 2; Ischemia; PlGF; Therapeutic angiogenesis; VEGF

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PLACENTAL GROWTH FACTOR; PROTEIN KINASE C; S6 KINASE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HINDLIMB; HUMANS; ISCHEMIA; MALE; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PREGNANCY PROTEINS; PULMONARY ARTERY; UMBILICAL VEINS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49749102835     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.12.012     Document Type: Article

References (22)

1. Ferrara N., Carver Moore K., and Chen H. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
2. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
3. Zachary I. VEGF signaling: integration and multitasking in endothelial cell biology. Biochem Soc Trans 31 (2003) 1171-1177
4. Hiratsuka S., Minowa O., Kuno J., Noda T., and Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95 (1998) 9349-9354
5. Autiero M., Waltenberger J., Communi D., et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9 (2003) 936-943
6. Luttun A., Tjwa M., Moons L., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8 (2002) 831-840
7. Pipp F., Heil M., Issbrucker K., et al. VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. Circ Res 10 (2003) 289-295
8. Carmeliet P., Moons L., Luttun A., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological condition. Nat Med 7 (2001) 575-583
9. Autiero M., Luttun M., Tjwa M., and Carmeliet P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. J Thromb Haemost 1 (2003) 1356-1370
10. Li B., Sharpe E.E., Maupin A.B., et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 20 (2006) 1495-1497
11. Odorisio T., Cianfarani F., Failla C.M., and Zambruno G. The placenta growth factor in skin angiogenesis. J Dermatol Sci 41 (2006) 11-19
12. Nagy J.A., Dvorak A.M., and Dvorak H.F. VEGF-A(164/165) and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med 13 (2003) 169-175
13. Rakic J.M., Lambert V., Devy L., et al. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization. Invest Ophthalmol Vis Sci 44 (2003) 3186-3193
14. Masaki I., Yonemitsu Y., Yamashita A., et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 90 (2002) 966-973
15. Onimaru M., Yonemitsu Y., Tanii M., et al. FGF-2 gene transfer can stimulate HGF expression, irrespective of hypoxia-mediated down regulation in ischemic limb. Circ Res 91 (2002) 723-730
16. Tsutsumi N., Yonemitsu Y., Shikada Y., et al. Essential role of PDGFa-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRa during angiogenesis. Circ Res 94 (2004) 1186-1194
17. Tanii M., Yonemitsu Y., Fujii T., et al. Diabetic microangiopathy in ischemic limb is a disease of disturbance of the platelet-derived growth factor-BB/protein kinase C axis but not of impaired expression of angiogenic factors. Circ Res 98 (2006) 55-62
18. Fujii T., Yonemitsu Y., Onimaru M., et al. Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization, critical role of the inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol 26 (2006) 2483-2489
19. Yong-Gang Y., Hoseong S., Yang, Zhiming C., Jennifer D., and Elia J.D. Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism. FEBS Lett 579 (2005) 1227-1234
20. Bojun Z., Jun C., and Mike B. Expression of placenta growth factor is regulated by both VEGF and hyperglycaemia via VEGFR-2. Microvasc Res 68 (2004) 239-246
21. Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 (FlT-1). IJBCB 33 (2001) 409-420
22. Christopher J.G., Peter L., Nhung T.H., et al. Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1. Cancer Res 61 (2001) 2696-2703